Pharmacological modulation of LMNA SRSF1-dependent splicing abrogates diet-induced obesity in mice.
Santo, J; Lopez-Herrera, C; Apolit, C; Bareche, Y; Lapasset, L; Chavey, C; Capozi, S; Mahuteau-Betzer, F; Najman, R; Fornarelli, P; Lopez-Mejía, I C; Béranger, G; Casas, F; Amri, E-Z; Pau, B; Scherrer, D; Tazi, J.
Int J Obes (Lond)
; 41(3): 390-401, 2017 03.
Artigo em Inglês | MEDLINE | ID: mdl-27916986
Treatment of obesity with celastrol.
WITHDRAWN: Interventions for treating obesity in children.
Drug interventions for the treatment of obesity in children and adolescents.
A systematic review of the anti-obesity and weight lowering effect of ginger (Zingiber officinale Roscoe) and its mechanisms of action.
Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide to Characterize Its Antiobesity Effects in Diet-Induced Obese Mice.
Medications to Treat Obesity Lack Patient-Oriented Evidence.
Postavení farmakoterapie v soucasné péci o obézní.
Interventions for treating obesity in children.
Synthesis and biological evaluation of novel chiral diazepine derivatives as bombesin receptor subtype-3 (BRS-3) agonists incorporating an antedrug approach.